David J. Brooks

Orcid: 0000-0003-2602-2518

Affiliations:
  • Imperial College London, Centre for Neuroscience, Department of Medicine, London, UK
  • Aarhus University, Institute of Clinical Medicine, Denmark


According to our database1, David J. Brooks authored at least 23 papers between 2002 and 2016.

Collaborative distances:
  • Dijkstra number2 of five.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

Online presence:

On csauthors.net:

Bibliography

2016
Using [<sup>11</sup>C]Ro15 4513 PET to characterise GABA-benzodiazepine receptors in opiate addiction: Similarities and differences with alcoholism.
NeuroImage, 2016

2014
Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [<sup>11</sup>C]MePPEP.
NeuroImage, 2014

2013
Binary classification of <sup>18</sup>F-flutemetamol PET using machine learning: Comparison with visual reads and structural MRI.
NeuroImage, 2013

Quantification of opioid receptor availability following spontaneous epileptic seizures: Correction of [<sup>11</sup>C]diprenorphine PET data for the partial-volume effect.
NeuroImage, 2013

Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
NeuroImage, 2013

2012
[<sup>18</sup>F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [<sup>18</sup>F]FDOPA and [<sup>11</sup>C]DASB PET study in Parkinson's disease.
NeuroImage, 2012

Can target-to-pons ratio be used as a reliable method for the analysis of [<sup>11</sup>C]PIB brain scans?
NeuroImage, 2012

2011
Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal <sup>18</sup>F-dopa PET study.
NeuroImage, 2011

BioSignalML - A meta-model for biosignals.
Proceedings of the 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2011

2010
Subject classification from [18F]flutemetamol data into categories of raised or low levels of beta-amyloid: Concordance between quantitative and visual assessment.
NeuroImage, 2010

The effects of zolpidem on in vivo binding of [C11]-flumazenil and [C11]-Ro15-4513.
NeuroImage, 2010

Correction of [11C]diprenorphine PET data for the partial-volume effect: Quantification of opioid receptor binding following spontaneous epileptic seizures.
NeuroImage, 2010

Pons as an alternative reference region in [18F]flutemetamol quantification of amyloidosis.
NeuroImage, 2010

Kinetic modeling of the adenosine A2A subtype receptor radioligand [11C]SCH442416 in humans.
NeuroImage, 2010

Molecular imaging in neurodegenerative diseases.
NeuroImage, 2010

Quantitation of adenosine A2A receptors availability in Parkinson's Disease patients with and without dyskinesias with [11C]SCH442416 PET using spectral analysis.
NeuroImage, 2010

Investigating the reproducibility of the novel Alpha-5 GABAA receptor PET ligand [11C]Ro15 4513.
NeuroImage, 2010

2009
Strategies for the generation of parametric images of [<sup>11</sup>C]PIB with plasma input functions considering discriminations and reproducibility.
NeuroImage, 2009

2007
Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [<sup>11</sup>C]diprenorphine test-retest data.
NeuroImage, 2007

A systematic comparison of kinetic modelling methods generating parametric maps for [<sup>11</sup>C]-(R)-PK11195.
NeuroImage, 2007

Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus.
NeuroImage, 2007

2006
Unsupervised Grammar Induction by Distribution and Attachment.
Proceedings of the Tenth Conference on Computational Natural Language Learning, 2006

2002
A H<sub>2</sub><sup>15</sup>O Positron Emission Tomography Study on Mental Imagery of Movement Sequences - The Effect of Modulating Sequence Length and Direction.
NeuroImage, 2002


  Loading...